Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Post-Acute COVID-19 Syndrome × Ipilimumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Sarcoma 1 Post-Acute COVID-19 Syndrome 1 Liver Neoplasms 1 Kidney Neoplasms 1 Fibrolamellar hepatocellular carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Kidney Cancer 1

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05597800 2022-10-28

LUNGVIR

Universita di Verona

Phase 2 Not yet recruiting

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡